Table 2 Effect of surgical site infection
From: Clinical study of a new skin antiseptic olanexidine gluconate in gastrointestinal cancer surgery
All | OLG group (n = 223) | Control group (n = 58) | P value |
|---|---|---|---|
Surgical site infection | 6 (2.7%) | 6 (10.3%) | 0.02 |
Superficial incisional | 5 (2.2%) | 5 (8.6%) | 0.0345 |
Deep incisional | 1 (0.5%) | 1 (1.7%) | 0.371 |
Open | OLG group (n = 91) | Control group (n = 42) | |
|---|---|---|---|
Surgical site infection | 2 (2.2%) | 4 (9.5%) | 0.0789 |
Superficial incisional | 2 (2.2%) | 4 (9.5%) | 0.0789 |
Deep incisional | 0 (0%) | 0 (0%) |
Laparoscopy | OLG group (n = 132) | Control group (n = 16) | |
|---|---|---|---|
Surgical site infection | 4 (3.0%) | 2 (12.5%) | 0.127 |
Superficial incisional | 3 (2.3%) | 1 (6.3%) | 0.37 |
Deep incisional | 1 (0.8%) | 1 (6.3%) | 0.205 |
Stomach | OLG group (n = 66) | Control group (n = 17) | |
|---|---|---|---|
Surgical site infection | 0 (0%) | 1 (5.9%) | 0.205 |
Superficial incisional | 0 (0%) | 1 (5.9%) | 0.205 |
Deep incisional | 0 (0%) | 0 (0%) |
Colon | OLG group (n = 157) | Control group (n = 41) | |
|---|---|---|---|
Surgical site infection | 6 (3.8%) | 5 (12.2%) | 0.0523 |
Superficial incisional | 5 (3.2%) | 4 (9.8%) | 0.0904 |
Deep incisional | 1 (0.6%) | 1 (2.4%) | 0.372 |